Skip to content
DeepViews

USANA Health Sciences Inc (USNA) — 分析摘要

USANA Health Sciences Inc(USNA)的市值为276.22百万美元,最近一年的营收同比增长了+8.3%。净利润率为1.2%。当前市盈率为-12.5倍。

核心要点

  • 营收同比变化+8.3%
  • 净利润率1.2%
  • 市盈率-12.5倍

与MEDICINAL CHEMICALS & BOTANICAL PRODUCTS板块的其他公司相比,USNA的营收增长为+8.3%,市盈率为-12.5倍。

[XNYS]

USANA Health Sciences Inc (USNA)

$14.95

前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR

市值
$276.22M
企业价值
$107.66M
市盈率
-12.5
股息率
0.00%
EV/EBITDA
3.4
公司简介
关于
关于 USANA Health Sciences Inc

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

行业

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

员工人数

1,570

总部

SALT LAKE CITY, UT

Exchange

XNYS

官网
Source: Polygon.io
评分
竞争壁垒
竞争壁垒
49
窄护城河

基于 4 年财务数据的系统性竞争优势评估

此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。

市场信号
估值
盈利
内部人交易
内部人备案活动

首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。

加载 SEC 内部人备案数据...
超级投资者
财务健康
财务健康

资本结构

总权益$570.97M
总债务$0.00M
债务权益比0.00
现金及等价物$168.56M

现金流

经营现金流$27.73M
自由现金流$15.93M
自由现金流率1.74%
P/FCF 比率17.34
Source: Polygon.io · SEC EDGAR
股息
最新资讯
Recent News

免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。